
Top Picks
Lexaria Bioscience Corp (LEXX) is destined for greater heights as its last quarter sales were 170 K
On Monday, Lexaria Bioscience Corp (NASDAQ: LEXX) was -8.49% drop from the session before settling in for the closing price of $0.98. A 52-week range